FDA’s Latest Move Might Not Be All It’s Chalked Up To Be

0
80

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. is highlighting the benefits of hormone-replacement therapy (HRT) for menopausal women.

“The [Food and Drug Administration (FDA)] is initiating the removal of broad black box warnings from hormone replacement therapy products for menopause,” he said Monday.

Hormone replacement treatments are sold in pill, patch, injection, spray and cream form, to name a few. All come with a black box label — the FDA’s highest safety-related warning. 

“Women may be under-utilizing approved therapies that can alleviate menopause symptoms and improve women’s health” because of these warning labels, HHS warned in a press statement released Monday. 

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here